SM
VIRX
Sabby Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-400,140
| Closed | -$166K | – | 104 |
|
|
2018
Q4 | $166K | Buy |
400,140
+121,956
| +44% | +$50.6K | 0.04% | 53 |
|
|
2018
Q3 | $556K | Sell |
278,184
-233,852
| -46% | -$467K | 0.07% | 36 |
|
|
2018
Q2 | $1.09M | Buy |
+512,036
| New | +$1.09M | 0.17% | 23 |
|
|
2018
Q1 | – | Sell |
-125,000
| Closed | -$461K | – | 116 |
|
|
2017
Q4 | $461K | Sell |
125,000
-118,638
| -49% | -$438K | 0.04% | 43 |
|
|
2017
Q3 | $473K | Buy |
243,638
+97,500
| +67% | +$189K | 0.03% | 40 |
|
|
2017
Q2 | $395K | Sell |
146,138
-8,024
| -5% | -$21.7K | 0.03% | 75 |
|
|
2017
Q1 | $632K | Sell |
154,162
-67,164
| -30% | -$275K | 0.03% | 71 |
|
|
2016
Q4 | $801K | Buy |
+221,326
| New | +$801K | 0.05% | 66 |
|
|
2015
Q3 | – | Sell |
-245,112
| Closed | -$738K | – | 245 |
|
|
2015
Q2 | $738K | Sell |
245,112
-29,688
| -11% | -$89.4K | 0.03% | 97 |
|
|
2015
Q1 | $673K | Buy |
+274,800
| New | +$673K | 0.03% | 90 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 155 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 162 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 148 |
|
|
2014
Q1 | – | Sell |
-111,847
| Closed | -$530K | – | 136 |
|
|
2013
Q4 | $530K | Buy |
+111,847
| New | +$530K | 0.03% | 51 |
|
|
2013
Q3 | – | Sell |
-180,300
| Closed | -$939K | – | 110 |
|
|
2013
Q2 | $939K | Buy |
+180,300
| New | +$939K | 0.06% | 29 |
|